Renal Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Recruiting
  • Sarcoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    U
    Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry
    Recruiting
    • Renal Cancer
      • Calgary, Alberta, Canada
      • +1 more
      2022-04-05
      Apr 5, 2022
      M
      Kidney Cancer DNA Registry
      Recruiting
      • Renal Cancer
      • salvia for germline DNA
      • +4 more
      • Basking Ridge, New Jersey
      • +6 more
      2022-04-01
      Apr 1, 2022
      N
      Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
      Recruiting
      • Malignant Neoplasms
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-03-31
        Mar 31, 2022
        N
        T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive - 2021
        Completed
        Has Results
        • Cervical Cancer
        • +4 more
        • Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-03-02
        Mar 2, 2022
        G
        A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
        Active, not recruiting
        • Melanoma
        • +7 more
        • Scottsdale, Arizona
        • +36 more
        2022-03-17
        Mar 17, 2022
        A
        Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
        Not yet recruiting
        • Renal Cell Carcinoma
        • +2 more
        • Blood collection
        • Tumour samples
        • Paris, France
        • +1 more
        2022-03-09
        Mar 9, 2022
        R
        Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
        Suspended
        • Metastatic Cancer
        • Renal Cancer
        • Indianapolis, Indiana
        • +3 more
        2022-02-25
        Feb 25, 2022
        N
        A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
        Recruiting
        • ccRCC
        • +9 more
        • Oral NKT2152
        • Scottsdale, Arizona
        • +5 more
        2022-03-09
        Mar 9, 2022
        B
        Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer - 2013
        Terminated
        Has Results
        • Melanoma
        • +2 more
        • Providence, Rhode Island
          Miriam Hospital
        2022-02-23
        Feb 23, 2022
        E
        Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
        Recruiting
        • Gynecologic Cancer
        • +14 more
        • Stereotactic body radiotherapy
        • Palliative RT
        • Gent, Belgium
        • +5 more
        2022-02-17
        Feb 17, 2022
        L
        A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers - 2022
        Completed
        • Head and Neck Squamous Cell Carcinoma
        • +10 more
        • Atlanta, Georgia
        • +6 more
        2022-03-01
        Mar 1, 2022
        A
        APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
        Recruiting
        • Solid Tumor
        • +8 more
        • APL-101 Oral Capsules
        • Gilbert, Arizona
        • +93 more
        2022-02-28
        Feb 28, 2022
        M
        Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
        Active, not recruiting
        • Renal Cancer
        • (EORTC QLQ-C30) questionnaire
        • EuroQol EQ-5D 7-item questionnaire
        • Los Angeles, California
        • +5 more
        2022-02-23
        Feb 23, 2022
        A
        9-ING-41 in Patients With Advanced Cancers
        Recruiting
        • Cancer
        • +24 more
        • San Francisco, California
        • +12 more
        2022-02-02
        Feb 2, 2022
        D
        Video Education With Result Dependent dIsclosure
        Not yet recruiting
        • Genetic Testing
        • +8 more
        • Video Education
        • Genetic Counseling
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        2022-01-26
        Jan 26, 2022
        B
        Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
        Active, not recruiting
        Has Results
        • Renal Cancer
        • Dendritic Cell Tumor Fusion Vaccine
        • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        2022-01-25
        Jan 25, 2022
        N
        Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. - 2021
        Completed
        • Breast Cancer
        • +5 more
        • Nashville, Tennessee
        • +11 more
        2022-01-28
        Jan 28, 2022
        H
        Stereotactic Radiotherapy for Renal Cancers
        Active, not recruiting
        • Renal Cancer
        • Stereotactic radiotherapy 4 x 8 Gy
        • +3 more
        • Dijon, France
        • +1 more
        2022-01-26
        Jan 26, 2022
        I
        Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
        Not yet recruiting
        • Bladder Cancer
        • Renal Cancer
        • cytokine-induced killer cells
        • Standard treatment according to the Clinical protocols
        • Minsk, Belarus
          Institute of Biophysics and Cell Engineering of National Academy
        2022-01-12
        Jan 12, 2022
        C
        Complications Associated With Partial Nephrectomy for Renal Cancer - 2019
        Completed
        • Renal Cancer
        • Partial Nephrectomy
        • partial nephrectomy
        • (no location specified)
        2021-12-24
        Dec 24, 2021
        A
        Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors
        Recruiting
        • Advanced Solid Tumors
        • +12 more
        • Continue PD-1/PD-L1 Inhibitors treatment
        • Discontinue PD-1/PD-L1-1 inhibitor
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        2021-12-22
        Dec 22, 2021
        I
        Open vs Robotic Assisted Partial Nephrectomy
        Active, not recruiting
        • Renal Cancer
        • Robotic-assisted partial nephrectomy
        • Open partial nephrectomy
        • Düsseldorf, Germany
        • +11 more
        2021-12-15
        Dec 15, 2021
        Z
        Renal Cancer Detection With Liquid Biopsy
        Recruiting
        • Renal Cancer
        • Oncocytoma
        • GaGnostic
        • Roskilde, Denmark
          Zealand University Hospital
        2021-12-10
        Dec 10, 2021
        C
        Microbiome Immunotherapy Toxicity and Response Evaluation
        Recruiting
        • Melanoma
        • +2 more
        • Bath, United Kingdom
        • +8 more
        2021-11-22
        Nov 22, 2021